Oramed Pharmaceuticals Inc. · NASDAQ:ORMP
Gabay Avraham sold 73,360 Oramed Pharmaceuticals Inc. shares (Form 4)
Traded Jul 1, 2026 · Filed Jul 2, 2026
On Jul 1, 2026, Gabay Avraham (Chief Financial Officer) sold 73,360 Oramed Pharmaceuticals Inc. shares at US$4.51 for US$331K, leaving 671,785 shares. Filed Jul 2, 2026 (Form 4).
- Sold
- 73,360 shares
- Price
- US$4.51
- Value
- US$331K
- Holding after
- 671,785 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | Sale | 73,360 | US$4.51 | 671,785 | Direct |
Source
Related
- Oramed Pharmaceuticals Inc.
- Gabay Avraham
- Oramed Pharmaceuticals Inc. shareholders
- Form 4 · Gabay Avraham · Oct 2, 2026
- Form 4 · Gabay Avraham · Sep 25, 2026
- Form 4 · Hexter Joshua · Oct 2, 2026
- Form 4 · Kidron Nadav · Sep 25, 2026
- Form 4 · Hexter Joshua · Sep 25, 2026
- Form 4 · Kidron Miriam · Sep 25, 2026
- Schedule 13G/A · Aquamarine Financial (Cayman) Ltd · Aug 14, 2026